Evidence map›Paper›PMID 8522332›Full record

ArticleHuman genetics1995

Germline mosaicism for an alanine to valine substitution at residue beta 140 in hemoglobin Puttelange, a new variant with high oxygen affinity.

H Wajcman, E Girodon, D Promé, M L North, F Plassa, I Duwig, J Kister, J P Bergerat, F Oberling, E Lampert

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Human genetics, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 11 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 1 country.

H WajcmanINSERM U91, Hôpital Henri Mondor, Créteil, France.
E Girodon
D Promé
M L North
F Plassa
I Duwig
J Kister
J P Bergerat
F Oberling
E Lampert
Hôpital d'Hautepierre · FRInstitut National de la Transfusion Sanguine · FRUniversité Paris-Est Créteil · FRBicêtre Hospital · FRCentre Hospitalier Universitaire Henri-Mondor · FRHôpitaux Universitaires Henri-Mondor · FRInserm · FRLaboratoire de Recherche en Sciences Végétales · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hb Puttelange [beta 140(H18)Ala-->Val] was found as a de novo mutation in two siblings of a French family suffering from polycythemia. Both parents were phenotypically normal and exclusion of paternity has been ruled out by the study of several polymorphic markers located on different chromosomes. The structural modification of Hb Puttelange was established by reversed-phase HPLC analysis of the tryptic digest of the abnormal chain. The amino acid composition of an abnormal beta T14 peptide revealed that one of the four residues of Ala was replaced by a Val. Tandem mass spectrometry demonstrated that the substitution concerned position beta 140 (H18). This hemoglobin displays an increased oxygen affinity that is responsible for the polycythemia. De novo mutations, as demonstrated again in the case of this variant, have the highest probabilities of detection when they lead to pathological manifestations. They may result either from a somatic mutation in a very early stage of the embryological development of the propositus or may have a parental origin with occurrence of a germline mosaicism. The study of the beta-globin gene indicated that this case of Hb Puttelange probably arose from a mutation affecting a part of the germline of the father, therefore leading to a true recurrence risk.

Indexed as

AlanineGenetic VariationMosaicismPoint MutationValineAdultAgedAmino Acid SequenceFathersFemaleGenetic MarkersGenomic ImprintingGlobinsHemoglobins, AbnormalHumansMacromolecular SubstancesAlanineGenetic MarkersGlobinshemoglobin PuttelangeHemoglobins, AbnormalMacromolecular SubstancesOxyhemoglobinsPeptide FragmentsValine

Identifiers

PMID8522332
OpenAlexW2092921901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.